Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors
异柠檬酸脱氢酶 1 突变抑制剂 ivosidenib 的耐药性可以通过替代二聚体界面结合抑制剂来克服
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-32436-4
Raphael Reinbold, Ingvild C Hvinden #, Patrick Rabe #, Ryan A Herold, Alina Finch, James Wood, Melissa Morgan, Maximillian Staudt, Ian J Clifton, Fraser A Armstrong, James S O McCullagh, Jo Redmond, Chiara Bardella, Martine I Abboud, Christopher J Schofield
